|
AMRN | Amarin Corp Plcuk |
|
|
AMRN | Amarin Corp Plcuk |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.08 |
| Leverage | 31.53% |
| Market Cap | $ 6.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -39.3m |
| Margin | -18.15% |
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.